Understanding the Hedgehog Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Necessary Step toward a Cure

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Signaling pathways critically regulate cell fate, impacting cancer development and treatment.
• Deregulation of signaling pathways and cancer stem cells drives tumor initiation and maintenance.
• Quiescent cancer stem cells resist chemotherapy, leading to disease relapse.

Purpose of the Study:

• To review the role of the conserved Hedgehog (Hh) signaling pathway in normal and leukemic stem cells.
• To dissect the Hh pathway's function in acute myeloid leukemia (AML).
• To evaluate innovative therapeutic strategies targeting Hh signaling in AML.

Main Methods:

• Literature review focusing on the Hedgehog signaling pathway.
• Analysis of Hh pathway's role in hematopoietic and leukemic stem cell regulation.
• Evaluation of therapeutic approaches for AML involving Hh signaling.

Main Results:

• The Hedgehog (Hh) signaling pathway regulates the cell cycle of hematopoietic and leukemic stem cells.
• Hh pathway deregulation is implicated in acute myeloid leukemia (AML) pathogenesis.
• Limited understanding exists regarding the full role of Hh signaling and GLI transcription factors in AML.
• Glasdegib, an SMO inhibitor, shows clinical activity in AML, but its mechanism requires clarification.

Conclusions:

• The Hedgehog signaling pathway is a key regulator in normal and leukemic stem cells, particularly in AML.
• Further research is essential to fully elucidate the role of GLI transcription factors for effective therapeutic targeting in AML.
• Targeting the Hh pathway, such as with SMO inhibitors like glasdegib, represents a promising avenue for novel AML treatments, though mechanisms need further investigation.